Bulbiferamide, an Antitrypanosomal Hexapeptide Cyclized via an <i>N</i>-Acylindole Linkage from a Marine Obligate <i>Microbulbifer</i>
Shiyang Lu, Zhiwei Zhang, Amit Raj Sharma, Junko Nakajima‐Shimada, Enjuro Harunari, Naoya Oku, Agus Trianto, Yasuhiro Igarashi
Abstract
UV absorption spectroscopy-guided fractionation of the culture extract of a marine obligate bacterium of the genus Microbulbifer yielded a novel cyclic hexapeptide, bulbiferamide ( 1 ). NMR spectroscopic and mass spectrometric analyses revealed the structure of 1 to be a cyclic tetrapeptide appending a ureido-bridged two amino acid unit. Notably, Trp is a junction residue, forming on one hand a very rare N -aminoacylated indole linkage for cyclization and on the other hand connecting the ureido-containing tail structure, which is an unprecedented way of configuring peptides. The component amino acids were determined to be l by the advanced Marfey’s method. Compound 1 displayed growth inhibitory activity against Trypanosoma cruzi epimastigotes with an IC 50 value of 4.1 μM, comparable to the currently approved drug benznidazole, while it was not cytotoxic to P388 murine leukemia cells at 100 μM.